Introduction: Influenza (flu) immunization is one of the major goals in Healthy People 2020 and recommended by AHA and ACC as secondary prophylaxis in a person with coronary and other cardiovascular diseases. However, little is known about flu vaccine coverage in young adults with cardiovascular disease (CVD). We aim to take a broader view by assessing the prevalence of flu vaccine by different CVDs among young adults in 2018. Methods: We included 117,978 young adults aged between age 18 to 44 years from BRFSS 2018 with information on the history of flu vaccination and CVD. Flu vaccination was defined as having a flu shot or a vaccine within the past 12 months. CVD was defined as having a history of either heart attack/myocardial infarction (MI), angina/congestive heart disease (CHD), or stroke. We used separate weighted univariate analyses to calculate prevalence for a different set of samples based on age groups (18-34 years, 35-44 years). Results: Overall flu vaccine rate in 2018 remained higher among adults aged 35-44 years compared to younger adults (18-34 years). The flu vaccination rate was comparatively lower among adults aged 35-44 with any CVD (26.7% vs. 28%) than those without any known CVD. In contrast, the vaccine rate was similar among younger adults aged 18-34 regardless of CVD history. Prevalence of flu vaccination was lower (19.5%) among adults aged 18-34 years with MI compared to those without MI (24.5%). Similarly, adults aged 35-44 years with MI reported lower flu vaccine prevalence (22.3% vs. 28.1%) compared to those without MI. Overall individuals with CHD reported higher vaccination rate than those without CHD. Stroke survivors aged 35-44 years reported significantly lower flu vaccine rate than those without stroke. In contrast, the rate was higher among younger stroke survivors (27.3% vs. 24.5%). Conclusions: There is a dire need to increase the annual flu vaccine rate among young adults with CVD to decrease overall morbidity and mortality.